Rhizoma Drynariae-derived nanovesicles reverse osteoporosis by potentiating osteogenic differentiation of human bone marrow mesenchymal stem cells via targeting ERα signaling

• Main Authors: Qing Zhao (Author), Junjie Feng (Author), Fubin Liu (Author), Qianxin Liang (Author), Manlin Xie (Author), Jiaming Dong (Author), Yanfang Zou (Author), Jiali Ye (Author), Guilong Liu (Author), Yue Cao (Author), Zhaodi Guo (Author), Hongzhi Qiao (Author), Lei Zheng (Author), Kewei Zhao (Author)
• Format: Book
• Published: Elsevier, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Although various anti-osteoporosis drugs are available, the limitations of these therapies, including drug resistance and collateral responses, require the development of novel anti-osteoporosis agents. Rhizoma Drynariae displays a promising anti-osteoporosis effect, while the effective component an...